Professor Robyn Ward AM
Professor Robyn Ward AM is Executive Dean of the Faculty of Medicine and Health, University of Sydney. She was formerly the Deputy Vice-Chancellor (Research) and Acting Executive Dean of Medicine at the University of Queensland.
Robyn has demonstrated sustained translational and clinical research performance at the highest level. Her research performance is supported by a consistently strong grant track record, including National Health and Medical Research Council (NHMRC) and Australian Research Council funding, as well as grants from cancer authorities. She has obtained over $38 million in competitive funding to support her research activities and has published over 270 articles, books and chapters including in high impact journals such as British Medical Journal, Journal of the National Cancer Institute, Nature Genetics and The New England Journal of Medicine.
As previous Director of the Translational Cancer Research Centre at University of New South Wales, Robyn has worked with a network of universities and hospitals to pursue the translational cancer research objectives of the Cancer Institute of NSW. Robyn’s contributions to medical research have been acknowledged through a Commonwealth Health Minister’s Award for Excellence in Health and Medical Research in 2004, the NSW Premier’s Award for Outstanding Cancer Researcher of the Year in 2007, and membership of the Order of Australia, awarded in 2013.
In addition to her clinical and research leadership experience, Robyn has contributed to the development of Commonwealth and NSW health policy, including through her current roles as Chair of the Commonwealth Medical Services Advisory Committee and member of the Pharmaceutical Benefits Advisory Committee. She is currently Co-Chair for Global Genomics Medicine Collaborative (G2MC), which is hosted by the Institute of Medicine of the National Academies in Washington and seeks to foster global collaboration in demonstrating the real world value of medical genomics to government and industry.